These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-003236-59 Double blind placebo controlled clinical investigation into the efficacy and tolerability of inhaled treprostinil in patients with severe pulmonary arterial hypertension. 2011-07-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000800-17 A 16-Week International, Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Combination with an Endothelin Re... 2008-09-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000801-50 A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arterial H... 2011-04-29 bad-data
Ongoing 2006-000804-18 An Open-Label Extension Trial of UT-15C SR in Subjects with Pulmonary Arterial Hypertension not-yet-due
Reported results 2008-005018-39 DISTOL-1:Digital Ischaemic Lesions in Scleroderma treated with Oral Treprostinil Diethanolamine: A randomized, double-blind, placebo controlled, multicenter study 2011-02-24 due-trials
Reported results 2008-006978-15 DISTOL-EXT:Digital Ischaemic Lesions in Scleroderma treated with Oral Treprostinil Diethanolamine: An open-label multicenter extension study 2011-09-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-009366-13 A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arterial Hypert... 2012-02-07 bad-data
Reported results 2011-004631-31 A 16 Week, Open Label, Multi-Centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of a Rapid Dose Titration Regimen of Subcutaneous Remodulin® Therapy in Subjects with Pulmon... 2014-03-20 due-trials
Listed as ongoing, but also has a completion date 2012-000097-26 A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects with Pulmonary Arterial Hypertension receiving background oral m... 2018-09-26 bad-data
Ongoing 2012-000098-21 An Open Label Extension Study of UT-15C in subjects with Pulmonary Arterial Hypertension- A long term follow up to protocol TDE-PH-310 not-yet-due
Ongoing 2017-000758-20 A Two-Part, Open-Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory Small Cell Lung Cancer not-yet-due